Literature DB >> 33735863

Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.

Monique E Cho1, Carol Sweeney2, Nora Fino2, Tom Greene2, Nirupama Ramkumar3, Yufeng Huang3, Ana C Ricardo4, Tariq Shafi5, Rajat Deo6, Amanda Anderson7, Katherine T Mills7, Alfred K Cheung3.   

Abstract

INTRODUCTION: Prorenin, a precursor of renin, and renin play an important role in regulation of the renin-angiotensin system. More recently, receptor-bound prorenin has been shown to activate intracellular signaling pathways that mediate fibrosis, independent of angiotensin II. Prorenin and renin may thus be of physiologic significance in CKD, but their plasma concentrations have not been well characterized in CKD.
METHODS: We evaluated distribution and longitudinal changes of prorenin and renin concentrations in the plasma samples collected at follow-up years 1, 2, 3, and 5 of the Chronic Renal Insufficiency Cohort (CRIC) study, an ongoing longitudinal observational study of 3,939 adults with CKD. Descriptive statistics and multivariable regression of log-transformed values were used to describe cross-sectional and longitudinal variation and associations with participant characteristics.
RESULTS: A total of 3,361 CRIC participants had plasma available for analysis at year 1. The mean age (±standard deviation, SD) was 59 ± 11 years, and the mean estimated glomerular filtration rate (eGFR, ± SD) was 43 ± 17 mL/min per 1.73 m2. Median (interquartile range) values of plasma prorenin and renin at study entry were 4.4 (2.1, 8.8) ng/mL and 2.0 (0.8, 5.9) ng/dL, respectively. Prorenin and renin were positively correlated (Spearman correlation 0.51, p < 0.001) with each other. Women and non-Hispanic blacks had lower prorenin and renin values at year 1. Diabetes, lower eGFR, and use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, and diuretics were associated with higher levels. Prorenin and renin decreased by a mean of 2 and 5% per year, respectively. Non-Hispanic black race and eGFR <30 mL/min/1.73 m2 at year 1 predicted a steeper decrease in prorenin and renin over time. In addition, each increase in urinary sodium excretion by 2 SDs at year 1 increased prorenin and renin levels by 4 and 5% per year, respectively. DISCUSSION/
CONCLUSIONS: The cross-sectional clinical factors associated with prorenin and renin values were similar. Overall, both plasma prorenin and renin concentrations decreased over the years, particularly in those with severe CKD at study entry.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  CKD; Prorenin; Renin

Mesh:

Substances:

Year:  2021        PMID: 33735863      PMCID: PMC8049970          DOI: 10.1159/000514302

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  32 in total

1.  (Pro)renin Receptor Is an Amplifier of Wnt/β-Catenin Signaling in Kidney Injury and Fibrosis.

Authors:  Zhen Li; Lili Zhou; Yongping Wang; Jinhua Miao; Xue Hong; Fan Fan Hou; Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2017-03-07       Impact factor: 10.121

Review 2.  Unraveling the Physiology of (Pro)Renin Receptor in the Distal Nephron.

Authors:  Tianxin Yang
Journal:  Hypertension       Date:  2017-02-27       Impact factor: 10.190

3.  Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Rajat Deo; Wei Yang; Abigail M Khan; Nisha Bansal; Xiaoming Zhang; Mary B Leonard; Martin G Keane; Elsayed Z Soliman; Susan Steigerwalt; Raymond R Townsend; Michael G Shlipak; Harold I Feldman
Journal:  Hypertension       Date:  2014-04-21       Impact factor: 10.190

Review 4.  Role of the Collecting Duct Renin Angiotensin System in Regulation of Blood Pressure and Renal Function.

Authors:  Nirupama Ramkumar; Donald E Kohan
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

5.  Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.

Authors:  Yuki Kaneshiro; Atsuhiro Ichihara; Mariyo Sakoda; Tomoko Takemitsu; A H M Nurun Nabi; M Nasir Uddin; Tsutomu Nakagawa; Akira Nishiyama; Fumiaki Suzuki; Tadashi Inagami; Hiroshi Itoh
Journal:  J Am Soc Nephrol       Date:  2007-05-09       Impact factor: 10.121

6.  Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet.

Authors:  Dinko Susic; Xiaoyan Zhou; Edward D Frohlich; Howard Lippton; Martha Knight
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-11       Impact factor: 4.733

7.  Characterization of angiotensin peptides in plasma of anephric man.

Authors:  D J Campbell; A Kladis; S L Skinner; J A Whitworth
Journal:  J Hypertens       Date:  1991-03       Impact factor: 4.844

8.  Microalbuminuria and increased plasma prorenin. Prevalence in diabetics followed up for four years.

Authors:  J A Luetscher; F B Kraemer
Journal:  Arch Intern Med       Date:  1988-04

Review 9.  The nephron (pro)renin receptor: function and significance.

Authors:  Nirupama Ramkumar; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2016-09-28

10.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Authors:  Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.